EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access

Deep Learning–Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation

Rayan A Ansari iD, Sabyasachi Bandyopadhyay iD, Rishi K Trivedi, Kelly A Brennan iD, Xichong Liu iD, Prasanth Ganesan iD, J Weston Hughes iD, Alexander C Perino iD, Euan A Ashley iD, Paul J Wang iD, Todd Coleman iD, Marco V Perez iD und 3 weitere

Circulation · 2026

DOI: 10.1161/circulationaha.125.077494 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Circulation, 2026. Verfasst von Rayan A Ansari und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine (R.A.A., S.B., K.A.B., X.L., P.G., A.C.P., E.A.A., P.J.W., M.V.P., S.M.N., A.J.R.), Stanford University, CA. Hauptthemen laut MEDLINE: Anti-Arrhythmia Agents, Deep Learning, Electrocardiography, Long QT Syndrome. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Insitutes of Health, American Heart Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Drug-induced QT prolongation after successful inpatient loading of class III antiarrhythmics may occur during routine outpatient care. Insertable cardiac monitors offer continuous signals but are limited by single-lead configuration. We hypothesized that a spatially aware deep learning system (3DRECON-QT) can reconstruct spatial information from a single lead vector to quantify QT/QTc and identify high-risk prolongation. METHODS: We developed 3DRECON-QT using a multitask encoder–decoder that ingests a 10-s single-lead signal, reconstructs 12 leads, and predicts QT/QTc. The model was developed using 12-lead ECGs with clinician-adjudicated QT/RR from a large health system and tested in an external center with different ECG hardware. Continuous monitoring performance was assessed in a public dofetilide‐loading data set with serial ECGs. In a real-world cohort of outpatients on dofetilide or sotalol presenting to the hospital or emergency room for any reason, rates of ventricular arrhythmias and QT prolongation were assessed. Device validation was tested in patients with insertable cardiac monitor recordings paired with clinical 12-lead ECGs. RESULTS: 3DRECON-QT classified prolonged QTc from single-lead signals with area under the receiver operating characteristics curve, 0.942 (mean absolute error, 17.5 ms) in the internal test set and 0.943 (mean absolute error, 21.1 ms) externally. During continuous dofetilide monitoring, predictions correlated with ground truth ( r , 0.851; mean absolute error, 17.8 ms; area under the receiver operating characteristics curve, 0.936 for prolonged QTc, 0.816 for ≥15% QTc rise). QTc prediction from true insertable cardiac monitor recordings showed r =0.824 and mean absolute error, 17.5 ms. In outpatients on class III antiarrhythmics (n=1676), 16.5% had high-risk QTc prolongation. Ventricular arrhythmia events were 3.97% versus 0.86% without prolongation (adjusted odds ratio, 4.24 [95% CI, 1.81–9.90]). 3DRECON-QT detected these events with area under the receiver operating characteristics curve 0.94 (F1 score, 0.60). CONCLUSIONS: A single-lead, deep-learning approach can achieve guideline-level measurement accuracy, enable continuous QTc surveillance from nonstandard ECG vectors, and identify clinically meaningful outpatient QTc prolongation associated with a >4-fold increase in serious ventricular arrhythmias. This strategy may enhance safety monitoring after class III antiarrhythmic initiation and support targeted intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Arrhythmia AgentsDeep LearningElectrocardiographyLong QT SyndromeAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedRetrospective StudiesSignal Processing, Computer-AssistedRisk Assessment

Stichwörter der Autor:innen

Torsades de Pointesanti-arrhythmia agentsarrhythmias, cardiacdeep learningdrug-related side effects and adverse reactionselectrocardiographymonitoring, ambulatory

Substanzen

Anti-Arrhythmia Agents

Autor:innen und Institutionen

  • Department of Medicine (R.A.A., S.B., K.A.B., X.L., P.G., A.C.P., E.A.A., P.J.W., M.V.P., S.M.N., A.J.R.), Stanford University, CA.
  • Department of Biomedical Data Science (R.A.A.), Stanford University, CA.
  • Cardiovascular Institute (S.B., K.A.B., X.L., P.G., A.C.P., E.A.A., P.J.W., M.V.P., S.M.N., A.J.R.), Stanford University, CA.
  • Department of Cardiology, Cedars-Sinai Medical Center, Los Angeles, CA (R.T., D.O.).
  • Department of Biomedical Informatics (J.W.H.), Columbia University Irving Medical Center, New York, NY.
  • Milstein Division of Cardiology (J.W.H.), Columbia University Irving Medical Center, New York, NY.

ORCID-Profile: Rayan A Ansari, Sabyasachi Bandyopadhyay, Kelly A Brennan, Xichong Liu, Prasanth Ganesan, J Weston Hughes, Alexander C Perino, Euan A Ashley, Paul J Wang, Todd Coleman, Marco V Perez, David Ouyang, Sanjiv M Narayan, Albert J Rogers

Förderung

  • NHLBI NIH HHS
  • National Insitutes of Health
  • American Heart Association
  • National Institutes of Health

Zitieren

APA

Ansari, R. A., Bandyopadhyay, S., Trivedi, R. K., Brennan, K. A., Liu, X., Ganesan, P., Hughes, J. W., Perino, A. C., Ashley, E. A., Wang, P. J., Coleman, T., Perez, M. V., Ouyang, D., Narayan, S. M., & Rogers, A. J. (2026). Deep Learning–Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation. Circulation. https://doi.org/10.1161/circulationaha.125.077494

Vancouver

Ansari RA, Bandyopadhyay S, Trivedi RK, Brennan KA, Liu X, Ganesan P, et al. Deep Learning–Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation. Circulation. 2026. doi:10.1161/circulationaha.125.077494

BibTeX
@article{Ansari2026,
  author = {Ansari, Rayan A and Bandyopadhyay, Sabyasachi and Trivedi, Rishi K and Brennan, Kelly A and Liu, Xichong and Ganesan, Prasanth and Hughes, J Weston and Perino, Alexander C and Ashley, Euan A and Wang, Paul J and Coleman, Todd and Perez, Marco V and Ouyang, David and Narayan, Sanjiv M and Rogers, Albert J},
  title = {Deep Learning–Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation},
  journal = {Circulation},
  year = {2026},
  doi = {10.1161/circulationaha.125.077494}
}
Kostenlos starten →